Ads
related to: astrazeneca stock split- Markets & Economy
View Our Latest Market Insights
and Get Economic Forecasts.
- Guide to Recessions
9 Things You Need to Know to
Prepare for a Recession.
- Market Volatility
Insights on Current Conditions from
Our Investment Professionals.
- PracticeLab®
Resources to Help You Build Your
Business and Engage Your Clients.
- Fixed Income Insights
View Our Latest Fixed Income
Investment Insights.
- Subscribe to Newsletter
Receive Our Latest Investment
Thinking In Your Inbox Each Week.
- Markets & Economy
interactivebrokers.com has been visited by 100K+ users in the past month
Search results
Could This Rare-Disease Drug Candidate Become a Blockbuster?
Motley Fool· 1 year agoBritish drugmaker AstraZeneca (NASDAQ: AZN) and U.S.-based Ionis Pharmaceuticals (NASDAQ: IONS) have...
Pharma Stock Roundup: FDA Nod to Updated PFE, MRNA COVID Jabs, & More
Zacks via Yahoo Finance· 9 months agoThe FDA authorizes Pfizer (PFE) and Moderna's (MRNA) updated mRNA-based COVID-19 vaccines. Novo...
The Stock-Split Stock Behind Ozempic and Wegovy Could Be Yours for Just $100
Motley Fool· 7 months agoIt's probably safe to assume that you've seen a commercial or heard a catchy jingle for any (if not...
Pharma Stock Roundup: AZN, SNY, ABBV Q2 Results, MRK, MRNA Cancer Jab in Phase III
Zacks via Yahoo Finance· 10 months agoThis week, AstraZeneca AZN, Sanofi SNY and AbbVie ABBV and Roche announced second-quarter earnings....
Dow Jones Futures Fall As Market Retreat Gains Steam; Elon Musk Makes This FSD Move
Investor's Business Daily· 2 years agoDow Jones futures fell sharply Monday morning, along with S&P 500 futures and Nasdaq futures, with...
Do These 3 New Moneymakers for AstraZeneca Make It a Buy?
Motley Fool· 2 years agoBig pharmas like AstraZeneca (NASDAQ: AZN) rise and fall based on how much money they can earn from their medicines on the market. With regulators at the European Medicines Agency (EMA) now ...
Could This New Drug Launch Be a Hit for Viatris?
Motley Fool· 1 year agoLast December, Viatris (NASDAQ: VTRS) and Kindeva Drug Delivery lost in court against AstraZeneca (NASDAQ: AZN) over a patent dispute regarding one of...
2 Best Biotech Stocks to Buy Right Now
Motley Fool· 12 months agoWhen done right, investing in pharmaceutical companies can be a lucrative endeavor. This is because as long as there are diseases and infections,...
Could This Vaccine Become Sanofi's Latest Blockbuster?
Motley Fool· 1 year agoSanofi (NASDAQ: SNY) and AstraZeneca's (NASDAQ: AZN) application for the respiratory syncytial virus...
IBD Stock Of The Day: How These Issues In 2023 Could Spark, Or Slam, Eli Lilly Stock
Investor's Business Daily· 1 year agoEli Lilly is the IBD Stock Of The Day as the company explores new methods of treating Alzheimer's...
